Home
About
Pricing
Log In
Back
AC8

This asset is not currently listed on any markets available through Pearler. The information on this page may be inaccurate or out of date.

Asset Logo

Auscann Group Holdings Ltd

๐Ÿ‡ฆ๐Ÿ‡บ ASX

๐Ÿ“ฆ LOGISTICS

๐Ÿ‘‘ Overview

๐Ÿ“ˆ Performance

๐Ÿ’ต Cost

๐Ÿค“ Advanced

๐Ÿ‘จโ€๐Ÿ‘ฉโ€๐Ÿ‘งโ€๐Ÿ‘ฆ Community

๐Ÿ“ˆ

-17.92%
Annual Growth

5 years average annual capital growth

๐Ÿ’ต

$ 500
Minimum Order

Due to regulatory requirements

๐ŸŒ

12
Pearlers Invested

Since January 2020

๐Ÿ‘‘ Overview

Key information
๐Ÿ”Ž Fund Overview

AusCann Group Holdings Ltd. engages in development, production, and distribution of cannabinoid-based medicines within Australia and internationally. The company is headquartered in Perth, Western Australia. The company has launched tetrahydrocannabinol and cannabidiol (THC/CBD) powder-based hard-shell capsules, based on the Companyโ€™s Neuvis platform, for the treatment of pain and related indications. Its products include CPAT-01, DermaCann and MicroMax. CPAT-01 is a liquid, oral veterinary medicine containing standardized tetrahydrocannabinol (THC) and cannabinoids (CBD) whole plant extracts in a proprietary ratio to target pain and inflammation in dogs. DermaCann is a CBD-derived nutraceutical in development for healthy skin and immune function in dogs with dermatological conditions. The product is a liquid oral oil formulation containing CBD in a patented combination with other bioactive lipids designed to target inflammation and immune modulation pathways.

๐Ÿ“ˆ Performance

Price History

0.00%

1M

All Time

Graph

Table

Unsure how much or often to invest?
๐Ÿ—“๏ธ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out โ†’
๐Ÿ’ต Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out โ†’
โฑ๏ธ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out โ†’

๐Ÿ’ต Costs

๐Ÿ’ต

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

๐Ÿ’ผ

N/A
Management Fee

Included in unit price, not charged by Pearler

๐Ÿ’ธ

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
๐Ÿ’ธ Net fee calculator

๐Ÿค“ Advanced information

Technical Info

๐Ÿ’ฐ Price*

$0.04

*Price may be up to 24 hours old

๐Ÿ‘ฉโ€๐Ÿ‘ฉโ€๐Ÿ‘ฆ Community Insights

How our community is investing

๐ŸŒ Pearlers invested in AC8

0

๐Ÿ“Š Total Capital Earnings

N/A

๐Ÿ”ƒ Average investment frequency

86 weeks

๐Ÿ’ต Average investment amount

$303

โฐ Last time a customer invested in AC8

434 days
AC8 investor breakdown
๐Ÿ’ต Income of investors

More than 200k

150k - 200k

100k - 150k

50k - 100k

Less than 50k

๐Ÿ‘ถ Age of investors

18 - 25

26 - 34

35 - 90

๐Ÿ™‹ Legal gender of investors

Female

Male

Pearlers who invest in AC8 also invest in...

Vanguard Australian Shares Index ETF

VAS

VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.

๐Ÿ™Œ Performance (5Yr p.a)

9.42%

๐Ÿ“Š Share price

$111.46 AUD

๐Ÿ‡ฆ๐Ÿ‡บ AUSTRALIA

๐Ÿงฑ MATERIALS

๐Ÿ’ธ FINANCIALS

โ›ณ๏ธ DIVERSIFIED

๐Ÿ“ˆ HIGH PRICE GROWTH

Find Out More

IVV.AX was created on 2000-05-15 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.

๐Ÿ™Œ Performance (5Yr p.a)

23.32%

๐Ÿ“Š Share price

$67.83 AUD

๐Ÿ“ˆ HIGH PRICE GROWTH

๐Ÿ‡บ๐Ÿ‡ธ UNITED STATES

VDHG.AX was created on 2017-11-20 by Vanguard. The fund's investment portfolio concentrates primarily on target outcome asset allocation. Vanguard Diversified High Growth Index ETF seeks to track the weighted average return of the various indices of the underlying funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax.

๐Ÿ™Œ Performance (5Yr p.a)

8.14%

๐Ÿ“Š Share price

$74.05 AUD

โ›ณ๏ธ DIVERSIFIED

๐ŸŒ GLOBAL

๐Ÿ“ˆ HIGH PRICE GROWTH

A200.AX was created on 2018-05-07 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. The ETF currently has 8332.1m in AUM and 198 holdings. A200.AX aims to track the performance of an index (before fees and expenses) comprising 200 of the largest companies by market capitalisation listed on the ASX.

๐Ÿ™Œ Performance (5Yr p.a)

10.06%

๐Ÿ“Š Share price

$149.58 AUD

๐Ÿ‡ฆ๐Ÿ‡บ AUSTRALIA

๐Ÿ’ธ FINANCIALS

โ›ณ๏ธ DIVERSIFIED

๐Ÿ“ˆ HIGH PRICE GROWTH

Cann Group Ltd. engages in the cultivation of medicinal cannabis and further processing into manufactured medicinal cannabis products. The company is headquartered in Melbourne, Victoria. The company went IPO on 2017-05-04. The principal activities of the Company include the cultivation of medicinal cannabis for both medicinal and research purposes pursuant to the licenses and permits issued to the Company, the development and manufacture (via third party arrangements) of finished product formulations, and the pursuit and execution of various supply agreements with third parties. The company operates through cultivation of the medicinal cannabis segment. The firm supplies a range of dried flower and oil products, as well as active pharmaceutical ingredients and extracts, to customers in Australia and around the world. The company also owns Satipharm and its patent-protected capsule technology. The firm's research and good manufacturing practices (GMP) manufacturing facilities are near Mildura, Victoria.

๐Ÿ™Œ Performance (5Yr p.a)

-19.31%

๐Ÿ“Š Share price

$0.01 AUD

๐Ÿ“ฆ LOGISTICS

Want more shares? Try these...

A-Cap Energy Ltd. engages in the exploration of minerals. The company is headquartered in Perth, Western Australia. The company went IPO on 2006-05-19. The Companyโ€™s flagship Letlhakane Uranium Project in Botswana hosts undeveloped uranium resources. The Wilconi Project is the Companyโ€™s first nickel-cobalt laterite project interest. The Letlhakane Uranium Project lies adjacent to Botswanaโ€™s main North-South infrastructure corridor that includes a sealed all-weather highway (the A1 Highway), a railway line and the national power grid. The Letlhakane Uranium Project has a Mining License designated ML 2016/16L. The Companyโ€™s Letlhakane Uranium Project remains as a project asset within the diversified minerals strategy. The Wilconi Project focuses on cobalt and nickel materials supply to the global electric vehicle (EV) market. The Wilconi Project is situated about 700 kilometers (km) from Perth. The Wiluna nickel-cobalt laterite deposit is located within the Archaean Norseman-Wiluna greenstone belt.

๐Ÿ“Š Share price

$0.07 AUD

NULL STOCK